Compare VVOS & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | BCTX |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4M | 18.5M |
| IPO Year | 2020 | N/A |
| Metric | VVOS | BCTX |
|---|---|---|
| Price | $2.07 | $9.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.25 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 123.1K | 57.6K |
| Earning Date | 11-19-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,317,000.00 | N/A |
| Revenue This Year | $17.96 | N/A |
| Revenue Next Year | $55.64 | $380.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.76 | N/A |
| 52 Week Low | $1.98 | $6.00 |
| 52 Week High | $7.95 | $106.50 |
| Indicator | VVOS | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 42.83 |
| Support Level | $1.98 | $11.38 |
| Resistance Level | $2.28 | $13.09 |
| Average True Range (ATR) | 0.13 | 1.14 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 25.71 | 10.47 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.